Literature DB >> 9829633

HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection.

C Jolivet-Reynaud1, P Dalbon, F Viola, S Yvon, G Paranhos-Baccala, N Piga, L Bridon, M A Trabaud, N Battail, G Sibai, M Jolivet.   

Abstract

Monoclonal antibodies (MAbs) were generated by immunizing mice with a truncated recombinant protein corresponding to the immunodominant region (residues 1-120) of hepatitis C virus (HCV) nucleocapsid protein. The specific recognition by either human sera or mouse monoclonal antibodies of overlapping peptides spanning the core region 1-120 as well as the comparison with epitopes described earlier allowed the fine mapping of HCV core. Within the region 1-120, the major antigenic domain could be restricted to the first 45 amino acids. Indeed, the peptide S42G (residues 2-45) allowed the detection of an anti-HCV core response by all anticore-positive human sera examined. According to their epitope localization, three groups of mouse MABs could be evidenced that were directed against different regions of core. Group II MAbs recognized a strictly linear epitope (QDVKF, residues 20-24), whereas group I MABs were directed against a conformational epitope mainly located at the amino acid residues (QIVGG, 29-33). The epitope of group III MABs was also conformational (PRGRRQPI, residues 58-65). These three epitopes appeared close but different from the three major human epitopes RKTKRNTN, VYLLPR, and GRTWAQPGYPWPLY (residues 7-17, 34-39, and 73-86, respectively). Group II MAB 7G12A8 and group I MAB 19D9D6 were used in a sandwich ELISA for the capture and the detection, respectively, of viral core antigen in sera of patients with chronic HCV infection. After treatment of sera with triton x 100 in acidic conditions, amounts of viral antigen as low as 20 pg/ml of sera could be detected.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829633     DOI: 10.1002/(sici)1096-9071(199812)56:4<300::aid-jmv3>3.0.co;2-8

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Characterization of a panel of monoclonal antibodies and mapping the epitopes of hepatitis C virus proteins.

Authors:  O V Masalova; A G Abdulmedzhidova; S N Atanadze; E I Lakina; YuA Semiletov; A N Burkov; T I Ulanova; V V Novikov; V K Pimenov; G Filds; YuE Khudyakov; A A Kushch
Journal:  Dokl Biochem Biophys       Date:  2002 Mar-Apr       Impact factor: 0.788

2.  Clustering of rare peptide segments in the HCV immunome.

Authors:  Angela Stufano; Giovanni Capone; Barbara Pesetti; Lorenzo Polimeno; Darja Kanduc
Journal:  Self Nonself       Date:  2010-02-03

3.  Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping.

Authors:  V Legros; C Jolivet-Reynaud; N Battail-Poirot; C Saint-Pierre; E Forest
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

4.  Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.

Authors:  P Maillard; K Krawczynski; J Nitkiewicz; C Bronnert; M Sidorkiewicz; P Gounon; J Dubuisson; G Faure; R Crainic; A Budkowska
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.

Authors:  P André; F Komurian-Pradel; S Deforges; M Perret; J L Berland; M Sodoyer; S Pol; C Bréchot; G Paranhos-Baccalà; V Lotteau
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Detection of hepatitis C virus core protein in serum by atomic force microscopy combined with mass spectrometry.

Authors:  Yuri D Ivanov; Anna L Kaysheva; Pavel A Frantsuzov; Tatyana O Pleshakova; Nikolay V Krohin; Alexander A Izotov; Ivan D Shumov; Vasiliy F Uchaikin; Vladimir A Konev; Vadim S Ziborov; Alexander I Archakov
Journal:  Int J Nanomedicine       Date:  2015-02-25

7.  Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2.

Authors:  A J Pérez-Berná; A S Veiga; M A R B Castanho; J Villalaín
Journal:  J Viral Hepat       Date:  2007-12-21       Impact factor: 3.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.